Visibility and Risk Management with Overhaul

As a result, the provider increases its involvement in the country’s pharma sector.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

A session investigates the drivers of these shortages and ways to mitigate them.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

A case study explores a way to potentially transform commercial organizations, while driving revenue growth.

A panel uncovers how distribution channels are aligning commercialization efforts.